Magnetite-PLGA microparticles for oral delivery of insulin

Jianjun Cheng, Christopher H. Yim, Benjamin A. Teply, Dennis Ho, Omid C. Farokhzad, Robert S. Langer

Research output: Chapter in Book/Report/Conference proceedingConference contribution

Abstract

Magnetic responsive particles were designed for use in oral delivery of insulin. Magnetite nanoparticles (12 nm average size) were synthesized and co-encapsulated with insulin into poly(lactide-co-glycolide) (PLGA) microparticles (4.6 ± 2.2 μm average particle size) through the double-emulsion method, The spherical structures of resulting microparticles were well maintained at magnetite content 5 wt % or less. Mice were gavaged with 125I-insulin-magnetite-PLGA microparticles and a circumferential trans-abdominal magnetic field was applied forty minutes after administration to retard the transit of the microparticles in the intestinal tract. As control, mice were similarly dosed without the subsequent trans-abdominal magnetic field. Mice were sacrificed, and the intestinal radioactivity was 101% and 145% higher in treated mice versus the control at 6 h and 12 h, respectively. A single administration of 50 unit/kg Humulin R-magnetite-PLGA microparticles to the fasted mice resulted in 66% reduction of blood glucose level in the presence of external magnetic field at 12 h, compared to 27% reduction in the absence of magnetic field,

Original languageEnglish (US)
Title of host publicationBiological and Bio-Inspired Materials and Devices
Pages109-114
Number of pages6
StatePublished - Dec 1 2005
Event2005 MRS Spring Meeting - San Francisco, CA, United States
Duration: Mar 28 2005Apr 1 2005

Publication series

NameMaterials Research Society Symposium Proceedings
Volume873
ISSN (Print)0272-9172

Other

Other2005 MRS Spring Meeting
CountryUnited States
CitySan Francisco, CA
Period3/28/054/1/05

Fingerprint

Ferrosoferric Oxide
Insulin
Magnetite
Magnetic fields
Magnetite Nanoparticles
Insulin, Regular, Human
Magnetite nanoparticles
Polyglactin 910
Radioactivity
Emulsions
Glucose
Blood Glucose
Blood
Particle size
polylactic acid-polyglycolic acid copolymer

ASJC Scopus subject areas

  • Materials Science(all)
  • Condensed Matter Physics
  • Mechanics of Materials
  • Mechanical Engineering

Cite this

Cheng, J., Yim, C. H., Teply, B. A., Ho, D., Farokhzad, O. C., & Langer, R. S. (2005). Magnetite-PLGA microparticles for oral delivery of insulin. In Biological and Bio-Inspired Materials and Devices (pp. 109-114). (Materials Research Society Symposium Proceedings; Vol. 873).

Magnetite-PLGA microparticles for oral delivery of insulin. / Cheng, Jianjun; Yim, Christopher H.; Teply, Benjamin A.; Ho, Dennis; Farokhzad, Omid C.; Langer, Robert S.

Biological and Bio-Inspired Materials and Devices. 2005. p. 109-114 (Materials Research Society Symposium Proceedings; Vol. 873).

Research output: Chapter in Book/Report/Conference proceedingConference contribution

Cheng, J, Yim, CH, Teply, BA, Ho, D, Farokhzad, OC & Langer, RS 2005, Magnetite-PLGA microparticles for oral delivery of insulin. in Biological and Bio-Inspired Materials and Devices. Materials Research Society Symposium Proceedings, vol. 873, pp. 109-114, 2005 MRS Spring Meeting, San Francisco, CA, United States, 3/28/05.
Cheng J, Yim CH, Teply BA, Ho D, Farokhzad OC, Langer RS. Magnetite-PLGA microparticles for oral delivery of insulin. In Biological and Bio-Inspired Materials and Devices. 2005. p. 109-114. (Materials Research Society Symposium Proceedings).
Cheng, Jianjun ; Yim, Christopher H. ; Teply, Benjamin A. ; Ho, Dennis ; Farokhzad, Omid C. ; Langer, Robert S. / Magnetite-PLGA microparticles for oral delivery of insulin. Biological and Bio-Inspired Materials and Devices. 2005. pp. 109-114 (Materials Research Society Symposium Proceedings).
@inproceedings{edd81d8c369546e4a556e62153eb59e5,
title = "Magnetite-PLGA microparticles for oral delivery of insulin",
abstract = "Magnetic responsive particles were designed for use in oral delivery of insulin. Magnetite nanoparticles (12 nm average size) were synthesized and co-encapsulated with insulin into poly(lactide-co-glycolide) (PLGA) microparticles (4.6 ± 2.2 μm average particle size) through the double-emulsion method, The spherical structures of resulting microparticles were well maintained at magnetite content 5 wt {\%} or less. Mice were gavaged with 125I-insulin-magnetite-PLGA microparticles and a circumferential trans-abdominal magnetic field was applied forty minutes after administration to retard the transit of the microparticles in the intestinal tract. As control, mice were similarly dosed without the subsequent trans-abdominal magnetic field. Mice were sacrificed, and the intestinal radioactivity was 101{\%} and 145{\%} higher in treated mice versus the control at 6 h and 12 h, respectively. A single administration of 50 unit/kg Humulin R-magnetite-PLGA microparticles to the fasted mice resulted in 66{\%} reduction of blood glucose level in the presence of external magnetic field at 12 h, compared to 27{\%} reduction in the absence of magnetic field,",
author = "Jianjun Cheng and Yim, {Christopher H.} and Teply, {Benjamin A.} and Dennis Ho and Farokhzad, {Omid C.} and Langer, {Robert S.}",
year = "2005",
month = "12",
day = "1",
language = "English (US)",
isbn = "1558998276",
series = "Materials Research Society Symposium Proceedings",
pages = "109--114",
booktitle = "Biological and Bio-Inspired Materials and Devices",

}

TY - GEN

T1 - Magnetite-PLGA microparticles for oral delivery of insulin

AU - Cheng, Jianjun

AU - Yim, Christopher H.

AU - Teply, Benjamin A.

AU - Ho, Dennis

AU - Farokhzad, Omid C.

AU - Langer, Robert S.

PY - 2005/12/1

Y1 - 2005/12/1

N2 - Magnetic responsive particles were designed for use in oral delivery of insulin. Magnetite nanoparticles (12 nm average size) were synthesized and co-encapsulated with insulin into poly(lactide-co-glycolide) (PLGA) microparticles (4.6 ± 2.2 μm average particle size) through the double-emulsion method, The spherical structures of resulting microparticles were well maintained at magnetite content 5 wt % or less. Mice were gavaged with 125I-insulin-magnetite-PLGA microparticles and a circumferential trans-abdominal magnetic field was applied forty minutes after administration to retard the transit of the microparticles in the intestinal tract. As control, mice were similarly dosed without the subsequent trans-abdominal magnetic field. Mice were sacrificed, and the intestinal radioactivity was 101% and 145% higher in treated mice versus the control at 6 h and 12 h, respectively. A single administration of 50 unit/kg Humulin R-magnetite-PLGA microparticles to the fasted mice resulted in 66% reduction of blood glucose level in the presence of external magnetic field at 12 h, compared to 27% reduction in the absence of magnetic field,

AB - Magnetic responsive particles were designed for use in oral delivery of insulin. Magnetite nanoparticles (12 nm average size) were synthesized and co-encapsulated with insulin into poly(lactide-co-glycolide) (PLGA) microparticles (4.6 ± 2.2 μm average particle size) through the double-emulsion method, The spherical structures of resulting microparticles were well maintained at magnetite content 5 wt % or less. Mice were gavaged with 125I-insulin-magnetite-PLGA microparticles and a circumferential trans-abdominal magnetic field was applied forty minutes after administration to retard the transit of the microparticles in the intestinal tract. As control, mice were similarly dosed without the subsequent trans-abdominal magnetic field. Mice were sacrificed, and the intestinal radioactivity was 101% and 145% higher in treated mice versus the control at 6 h and 12 h, respectively. A single administration of 50 unit/kg Humulin R-magnetite-PLGA microparticles to the fasted mice resulted in 66% reduction of blood glucose level in the presence of external magnetic field at 12 h, compared to 27% reduction in the absence of magnetic field,

UR - http://www.scopus.com/inward/record.url?scp=34249950077&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34249950077&partnerID=8YFLogxK

M3 - Conference contribution

AN - SCOPUS:34249950077

SN - 1558998276

SN - 9781558998278

T3 - Materials Research Society Symposium Proceedings

SP - 109

EP - 114

BT - Biological and Bio-Inspired Materials and Devices

ER -